• ACAL Energy

  Participated · Equity · Jun 2011

  ACAL Energy is a Runcorn, Halton, UK-based developer of low-cost Proton Exchange Membrane (PEM) fuel cell systems, modules and consumable chemicals. Led by CEO Dr SB Cha, the company targets stationary, residential and automotive applications requiring more than 1 kW of power. It intends to use recent funding to develop its first stationary power product and to demonstrate a stationary power prototype at Solvay Ltd’s Warrington site later this year. The company also plans to accelerate development of aspects of its technology for automotive applications. ACAL Energy closed a £6.1m funding round, providing capital to advance product development and field demonstration.

• Eight19

  Led · Equity · Sep 2010

  Eight19 develops and manufactures high-performance, lower-cost plastic solar cells (organic photovoltaics) using roll-to-roll flexible processes. The company spun out from the Carbon Trust’s Cambridge University–TTP Advanced Photovoltaic Research Accelerator and was created in partnership with Professor Sir Richard Friend, Professor Henning Sirringhaus, Professor Neil Greenham and technology development company TTP. Its core product focus is on semiconducting plastics fabricated on flexible materials to enable low-temperature, high-throughput manufacturing. Eight19 pursues a design-for-manufacture strategy that combines specific product performance characteristics with low cost of energy. The company highlights advantages of organic solar cells including reduced material supply constraints and lower toxicity compared with other thin-film platforms, plus potential ease of installation and simplified manufacturing integration. It will use the recently raised capital to develop product prototypes and will continue active engagement with the Cavendish Laboratory and its research output.

• Concurrent Thinking

  Led · Equity · Jun 2010

  Concurrent Thinking develops ConcurrentCOMMAND, an open framework that lets channel partners and end-users deploy system and application software and monitor hardware, software and environmental conditions to ensure continuity, minimise costs and optimise performance. The product is built using Web 2.0 technologies and can be used from any internet-capable device. The company plans to use the new funding to grow internationally and to reach larger markets within High Performance Computing and more mainstream computing sectors. A particular focus is exploiting the technology for systemic energy management within data‑centre environments. In conjunction with the funding, the company announced it spun out from Streamline Computing Ltd. The company is based in Warwick, UK.

• Intamac Systems

  Participated · Equity · Jun 2010

  Intamac Systems offers broadband and mobile home monitoring solutions aimed at home security, home automation, energy management, video and telecare for corporate partners. The company works with partners across Europe, North America and Australia. Its customers include D-Link, British Telecom, Technicolor, Alcatel Lucent and IAG, and several leading European telcos and utilities are piloting its systems. Intamac received a £4m equity investment to support expansion and product development. The funding is earmarked to help the company expand abroad and to develop new consumer products and services in the Smart Energy space. No operating metrics were disclosed in the article. Intamac Systems develops a web-based platform that enables consumers to remotely monitor and control their home environment over a broadband connection. The platform is designed to work with intelligent household devices including alarms, locks, cameras, electrical appliances and utility meters that can send and receive information wirelessly. Users access a simple web interface via a computer or mobile phone to manage devices and receive interactive services. Intamac positions the platform to enable a broad range of new products and interactive services for consumers. The company was founded in September 2000 and is led by CEO Kevin Meagher, with head offices and development facilities in Northampton and technical system support facilities housed in a commercial ISP in Leeds. Financially, the company has received a £1m equity investment from venture capital firm Seraphim Capital.

• Green Biologics

  Participated · Equity · Jun 2010

  Green Biologics is a UK-based renewable chemical company that uses a fermentation platform to convert biomass into n-butanol and acetone for a range of consumer and industrial applications including food, cosmetics, personal care, household and industrial cleaners, paints and inks. The company has transitioned from a development-stage to a commercial company and acquired the assets of the Central MN Ethanol Co-op, a 21 million gallon per year ethanol plant in Little Falls, Minnesota, through its Central MN Renewables LLC affiliate. The $76M financing will support that plant acquisition, repurposing the Minnesota plant to produce n-butanol and acetone, and funding Green Biologics’ advanced process technology platform. The round comprised $42M in equity and $34M in debt. Commercial-scale construction is expected throughout this year; the company plans to shut down the existing plant in Q1 next year to tie in the new technology and aims to be in full production by the end of Q2. This raise follows a $25M equity round in December 2013, bringing total fundraising to just over $100M since late 2013. Green Biologics produces renewable n-butanol using advanced fermentation technology from a wide range of feedstocks, including corn, agricultural and forestry residues, and municipal solid waste. Its core products are renewable C4 chemicals and advanced biofuels, with n-butanol serving as a backbone chemical for paints, coatings, adhesives, inks, plastics, pharmaceuticals, food ingredients, household cleaners and personal care products in a global market exceeding $6 billion. The company operates globally in Europe, North America, China, India and Brazil and maintains offices and laboratories in Milton Park, Abingdon, Oxfordshire, U.K., with U.S. offices and pilot facilities in Gahanna, Ohio. Green Biologics plans to use financing to advance commercialization efforts and proceed toward full commercial production. The company was founded in Oxford in 2003. It recently closed a $25 million Series B growth equity financing to support those commercialization plans. Green Biologics is an Abingdon, UK-based technology provider for biobutanol production. The company provides a technology to produce renewable butanol and other chemicals from waste and agricultural by-products. It completed a £4.9m financing round to support its commercial plans. Proceeds will be used to roll out its technology and commercialisation plans in key markets including China, India, Brazil and the US. The round included participation from existing venture partners as well as management and founder investors. As part of the financing, two investors joined the company’s board.

No current team members are available.